A critical breakthrough in cancer study is occurring with the use of nanobodies to reactivate mutated p53. This essential cancer protector protein is frequently disabled in various forms of malignancies, leading https://dirstop.com/story29807481/mini-antibodies-revive-p53-a-potential-pathway-for-malignant-treatment